BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18673340)

  • 1. Ultrastructural localization of glycoprotein IIIa (GPIIIa, beta 3 integrin) on placental syncytiotrophoblast microvilli: implications for platelet alloimmunization during pregnancy.
    Kumpel BM; Sibley K; Jackson DJ; White G; Soothill PW
    Transfusion; 2008 Oct; 48(10):2077-86. PubMed ID: 18673340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Anti-HPA-1a Standard Antibodies React with the β3 Integrin Subunit but not with αIIbβ3 and αvβ3 Complexes.
    Bayat B; Traum A; Berghöfer H; Werth S; Zhu J; Bein G; Sachs UJ; Santoso S
    Thromb Haemost; 2019 Nov; 119(11):1807-1815. PubMed ID: 31587244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
    Kjeldsen-Kragh J; Bengtsson J
    Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype and mRNA expression of syncytiotrophoblast microparticles isolated from human placenta.
    Kumpel B; King MJ; Sooranna S; Jackson D; Eastlake J; Cheng R; Johnson M
    Ann N Y Acad Sci; 2008 Aug; 1137():144-7. PubMed ID: 18837939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of human platelet antigen-1a alloantibodies in cases of fetomaternal alloimmune thrombocytopenia using recombinant β3 integrin fragments coupled to fluorescently labeled beads.
    Chong W; Metcalfe P; Mushens R; Lucas G; Ouwehand WH; Navarrete CV
    Transfusion; 2011 Jun; 51(6):1261-70. PubMed ID: 21166681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic and structural analysis of eight novel domain-deletion beta3 integrin peptides designed for detection of HPA-1 antibodies.
    Stafford P; Ghevaert C; Campbell K; Proulx C; Smith G; Williamson LM; Ranasinghe E; Watkins NA; Huntington JA; Ouwehand WH
    J Thromb Haemost; 2008 Feb; 6(2):366-75. PubMed ID: 18045240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.
    Bakchoul T; Greinacher A; Sachs UJ; Krautwurst A; Renz H; Harb H; Bein G; Newman PJ; Santoso S
    Blood; 2013 Jul; 122(3):321-7. PubMed ID: 23645838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
    de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M
    Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
    Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
    Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three novel beta3 domain-deletion peptides for the sensitive and specific detection of HPA-4 and six low frequency beta3-HPA antibodies.
    Stafford P; Garner SF; Huiskes E; Kaplan C; Kekomaki R; Santoso S; Tsuno NH; Watkins NA; Ouwehand WH
    J Thromb Haemost; 2008 Feb; 6(2):376-83. PubMed ID: 18031296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of human antibodies targeting human platelet antigen (HPA)-1a.
    Oosterhoff JJ; Linty F; Visser R; de Vos T; Hofstede-van Egmond S; van de Weerd M; Porcelijn L; de Haas M; van der Schoot E; Vidarsson G
    Transfusion; 2024 May; 64(5):893-905. PubMed ID: 38400657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe fetomaternal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-1a in a mother with a rare and silenced ITGB3*0101 (GPIIIa) allele.
    Smith GA; Rankin A; Riddle C; Cheetham-Wilkinson C; Ranasinghe E; Ouwehand WH; Watkins NA
    Vox Sang; 2007 Nov; 93(4):325-30. PubMed ID: 18070277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia.
    Bakchoul T; Kubiak S; Krautwurst A; Roderfeld M; Siebert HC; Bein G; Sachs UJ; Santoso S
    Transfusion; 2011 Nov; 51(11):2455-61. PubMed ID: 21564107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel assay for the detection of anti-human platelet antigen antibodies (HPA-1a) based on peptide aptamer technology.
    Thibaut J; Mérieux Y; Rigal D; Gillet G
    Haematologica; 2012 May; 97(5):696-704. PubMed ID: 22133781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys.
    Tiller H; Killie MK; Husebekk A; Skogen B; Ni H; Kjeldsen-Kragh J; Øian P
    Acta Obstet Gynecol Scand; 2012 Jan; 91(1):79-86. PubMed ID: 21895612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human platelet antigen 1a epitopes are dependent on the cation-regulated conformation of integrin α(IIb)β(3) (GPIIb/IIIa).
    Allen DL; Abrahamsson S; Murphy MF; Roberts DJ
    J Immunol Methods; 2012 Jan; 375(1-2):166-75. PubMed ID: 22036924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution mapping of the polyclonal immune response to the human platelet alloantigen HPA-1a (Pl
    Zhi H; Ahlen MT; Thinn AMM; Weiler H; Curtis BR; Skogen B; Zhu J; Newman PJ
    Blood Adv; 2018 Nov; 2(21):3001-3011. PubMed ID: 30413435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia.
    Bakchoul T; Boylan B; Sachs UJ; Bein G; Ruan C; Santoso S; Newman PJ
    Transfusion; 2009 Feb; 49(2):265-70. PubMed ID: 19000229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional platelet fibrinogen receptor with a deletion in the cysteine-rich repeat region of the beta(3) integrin: the Oe(a) alloantigen in neonatal alloimmune thrombocytopenia.
    Santoso S; Kiefel V; Richter IG; Sachs UJ; Rahman A; Carl B; Kroll H
    Blood; 2002 Feb; 99(4):1205-14. PubMed ID: 11830467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia.
    Peterson JA; Gitter ML; Kanack A; Curtis B; McFarland J; Bougie D; Aster R
    Transfusion; 2010 Feb; 50(2):324-33. PubMed ID: 19821948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.